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An impaired capacity of adipose tissue expansion leads to adipocyte 
hypertrophy, inflammation and insulin resistance (IR) under positive energy 
balance. We previously showed that a grape pomace extract, rich in flavonoids 
including quercetin (Q), attenuates adipose hypertrophy. This study investigated 
whether dietary Q supplementation promotes adipogenesis in the epididymal 
white adipose tissue (eWAT) of rats consuming a high-fat diet, characterizing 
key adipogenic regulators in 3T3-L1 pre-adipocytes. Consumption of a high-fat 
diet for 6 weeks caused IR, increased plasma TNFα concentrations, eWAT 
weight, adipocyte size and the eWAT/brown adipose tissue (BAT) ratio. These 
changes were accompanied by decreased levels of proteins involved in 
angiogenesis, VEGF-A and its receptor 2 (VEGF-R2), and of two central 
adipogenic regulators, i.e. PPARγ and C/EBPα, and proteins involved in mature 
adipocyte formation, i.e. fatty acid synthase (FAS) and adiponectin. Q 
significantly reduced adipocyte size and enhanced angiogenesis and 
adipogenesis without changes in eWAT weight and attenuated systemic IR and 
inflammation. In addition, high-fat diet consumption increased eWAT hypoxia 
inducible factor-1 alpha (HIF-1α) levels and those of proteins involved in 
adipose inflammation (TLR-4, CD68, MCP-1, JNK) and activation of 
endoplasmic reticulum (ER) stress, i.e. ATF-6 and XBP-1. Q mitigated all these 
events. Q and quercetin 3-glucoronide prevented TNFα-mediated 
downregulation of adipogenesis during 3T3-L1 pre-adipocytes early 
differentiation. Together, Q capacity to promote a healthy adipose expansion 
enhancing angiogenesis and adipogenesis may contribute to reduced adipose 















Abbreviations: BAT, brown adipose tissue; C/EBP, CCAAT/enhancer-binding 
protein; eWAT, epididymal white adipose tissue; ER, endoplasmic reticulum; 
FAS, fatty acid synthase; G, quercetin 3-glucuronide; HFD, high-fat diet group; 
HFD+Q, high-fat diet group plus quercetin;  HIF-1α, hypoxia inducible factor-1 
alpha; IR, insulin resistance; MCP-1, monocyte chemotactic protein-1; PPARγ, 
peroxisome proliferator-activated receptor gamma; Q, quercetin; TLR-4, toll like 
type receptor 4; TNFα, tumor necrosis factor alpha; VEGF, vascular endothelial 
growth factor; VEGF-R2, vascular endothelial growth factor-receptor 2.  
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1. Introduction 
Obesity is one of the main public health concerns worldwide [1, 2]. Increased 
adiposity, mainly visceral adipose tissue, is strongly associated with insulin 
resistance (IR), type 2 diabetes and cardiovascular disease, among others. In 
the presence of excessive caloric intake, the fat mass increases as a 
consequence of an increase of adipocyte number (hyperplasia) and/or size 
(hypertrophy). It is well established that adipocyte hypertrophy is a major 










redox signaling cascades leading to the up-regulation of pro-inflammatory 
adipocytokine expression (e.g., tumor necrosis factor alpha (TNFα), monocyte 
chemotactic protein-1 (MCP-1), Interleukin-6 and organelle stress (e.g., 
endoplasmic reticulum (ER) stress) leading to adipose dysfunction [4]. This pro-
inflammatory scenario contributes to the recruitment and infiltration of 
macrophages. Macrophages express the Toll like receptors-4 (TLR-4), an 
innate immune receptor that binds to endogenous and exogenous ligands such 
as lipopolysaccharides. TLR-4-ligand binding leads to the activation of the 
nuclear transcription factor kappa B (NF-κB) that prom tes the transcription of 
various genes involved in the inflammatory response contributing to perpetuate 
the inflammatory scenario in adipose tissue and adiposity-associated systemic 
IR [5].  
Adipogenesis is the process by which precursor stem cells differentiate into 
mature adipocytes. It involves the activation of signaling cascades which 
coordinate the expression of genes responsible for adipocyte differentiation [6]. 
Both peroxisome proliferator-activated receptor gamma (PPARγ) and 
CCAAT/enhancer-binding proteins (C/EBP) are central adipogenic regulators 
that positively control each other and cooperate in adipose tissue differentiation. 
In addition, fat expansion requires an adequate vascularization to enable tissue 
delivery of oxygen and nutrients. The vascular endothelial growth factor-A 
(VEGF-A) acting through its receptor 2 (VEGF-R2), is the main proangiogenic 
factor associated with adipogenesis. Adipose tissue inflammation can 
downregulate PPARγ expression and impair the normal adipogenesis process 










adipocyte hypertrophy, ectopic fat deposition, inflammation and ER stress [4, 8, 
9].  
Diet can play a major role in the prevention of adiposity-associated pathologies. 
Flavonoids are the most abundant phenolic compounds in the plant kingdom.  
The ability of flavonoids to modulate cell signaling could contribute to the health 
benefits associated with consumption of fruits and vegetables [10]. Among 
flavonoids, the flavonol quercetin (Q) is one of the most abundant flavonoids in 
human dietary sources such as onions, broccoli, apples, blueberries, tea, 
grapes, and several other plants and derived products, and has been proposed 
to mitigate obesity-associated pathologies [11-13].  Q was shown to exert anti-
inflammatory actions both in vivo and in vitro. We previously reported that Q 
downregulated pro-inflammatory signaling cascades (mitogen-activated kinases 
JNK and p38) and adipocytokine expression (resistin, MCP-1, TNFα) in the 
epididymal white adipose tissue (eWAT) from high fructose fed rats and in 3T3-
L1 adipocytes [12]. Q also decreases adipose macrophage infiltration in mice 
fed a Western style diet [13, 14].  
We previously showed that a grape pomace extract, rich in flavonoid 
compounds including Q, protects high-fat diet-induced adipose hypertrophy and 
dysfunction in rats [15]. Thus, identifying the active components responsible for 
the capacity of grape pomace extract to protect against diet-induced adipose 
dysfunction is relevant in order to generate diets that can mitigate obesity 
associated pathologies. In this study, we tested the hypothesis that Q can 
protect high-fat diet-induced adipose hypertrophy and inflammation promoting 










main metabolite quercetin 3-glucuronide during adipocyte differentiation were 
investigated in 3T3-L1 pre-adipocytes. 
 
2. Materials and methods 
 
2.1. Materials 
Total cholesterol, HDL cholesterol and triglyceride assay kits were purchased 
from GTLab. (Buenos Aires, Argentina). Glucose was measured using a 
glucometer (Accu-Chek Performa, Roche, Buenos Aires, Argentina). The Ultra-
Sensitive Insulin ELISA Kit was purchased from Crystal Chem (Downers Grove, 
IL, USA). The primary antibody for VEGF-A (MAB293) was from R & D Systems 
(Minneapolis, MN). Primary antibodies for adiponectin (C45B10) #2789, fatty 
acid synthase (C20G5) #3180, C/EBPα (D56F10) #8178 and PPARγ (C26H12) 
#2435 were obtained from Cell Signaling Technology (Danvers, MA). Primary 
antibodies  for PPARγ (sc-7273), TLR-4 (sc-293072), HIF-1α (sc-13515), ATF-6 
(sc-22799), XBP-1 (sc-32136), Flk-1/VEGF-R2 (sc-504), CD68 (sc-59103), 
MCP-1 (sc-1785), JNK (FL) sc-572 and p-JNK ((Thr183/Tyr185)) (sc-6254) 
were from Santa Cruz Biotechnology (Santa Cruz, CA). Nitrocellulose 
membranes were obtained from BIO-RAD (Hercules, CA). All other chemicals 
were purchased from Sigma Aldrich Co (St. Louis, MO).  
Mouse embryo 3T3-L1 pre-adipocyte cells line were obtained from American 
Type Culture Collection, (Manassas, VA). Modified Medium from Dulbecco 
Eagle (DMEM) was obtained from ThermoFisher (11965-092), fetal bovine 
serum (FBS) from GIBCO (10437-028), dexamethasone from Sigma (#D-1756) 














2.2. Animals and animal care 
All procedures were approved by the Institutional Animal Care and Use 
Committee of the School of Medical Science, University of Cuyo (Protocol 
approval N° 36/2014). Rats were housed under controlled conditions of 
temperature (23°C±1°C) and light (12 h light/12 h dark cycle). Eight week (w) 
old male Sprague Dawley rats were randomly divided (7 rats/group) into three 
experimental groups and fed for 6 w the following diets: (1) a standard chow 
diet (Control group) (Ctrl), (2) the chow diet containing 40% calories from fat 
(w/w) (20% bovine and 20% porcine fat) (HFD) and (3) the HFD  supplemented 
with 20 mg Q/kg body weight (bw) (HFD+Q). The amount of Q was chosen 
based on our previous study [12] and on studies by other groups in rat models 
of obesity or hypertension [11, 16]. The fat and Q were incorporated into the 
pellet mixture as previously described [12, 15]. Every 2–3 days (d), pellets were 
weighed and dispensed. Body weight was recorded weekly. Food and water 
intakes were determined three times a w. After 6 w in the dietary treatments and 
after an overnight fast, rats were weighed and anesthetized with ketamine (50 
mg/kg bw) and acepromazine (1 mg/kg bw), and blood was collected from the 
abdominal aorta into EDTA-containing tubes. Plasma was obtained after 
centrifugation at 1000×g for 15 min at 4°C. eWAT and subscapular brown 
adipose tissue (BAT) were collected and weighed. Tissues were flash frozen in 










was immediately fixed in 10% (w/v) neutral formalin solution for 24 h and 
processed for histological analysis. 
 
 
2.3. Metabolic measurements 
Glucose was measure in blood collected from the tail using a glucometer. For 
glucose tolerance tests (GTT), overnight fasted rats were injected with D-
glucose (2 g/kg bw), and blood glucose was measured before and at 15, 30, 60, 
and 120 min post-injection as previously described [17, 18]. GTT was done after 
4 w on the respective diets. At the end of the study, plasma total cholesterol, 
triglycerides, and HDL cholesterol concentrations were determined by 
enzymatic colorimetric methods using commercial kits. Insulin was measured 
using the Ultra-Sensitive Insulin ELISA kit and IR was evaluated using the 
homeostasis model assessment parameter (HOMA-IR) using the following 
formula: HOMA-IR (mg/dL × μU/mL) = fasting glucose (mg/dL) × insulin in 
fasting (μU/mL)/405. Plasma free fatty acids (FFA) and TNFα concentrations 
were determined using commercial kits (HR Series NEFA-HR, Fujifilm Wako 
Diagnostics, CA, USA and RayBiotech, Inc., Norcross, GA, USA, respectively). 
Assays were ran according to the manufacturer’s protocol. 
 
 
2.4. Western blots analysis 
Tissue homogenates were prepared as previously described [12, 17]. Aliquots 
of total homogenates containing 25–40 μg protein were separated by reducing 










nitrocellulose membranes. Membranes were blocked for 2 hours (h) in 5% (w/v) 
nonfat milk and subsequently incubated in the presence of the corresponding 
primary antibodies (1:1000 dilution) overnight at 4°C. After incubation for 90 min 
at room temperature in the presence of secondary antibodies (either HRP or 
biotinylated antibodies, followed in the later case by 1 h incubation with 
streptavidin), the conjugates were visualized and quantified by 
chemiluminescence detection in a Luminescent Analyzer Image Reader (LAS-
4000) (Fujifilm, Japan). The densitometric analysis was performed using the 
Image J Program.   
 
2.5. Histological analysis 
Adipocyte hypertrophy degree was evaluated in eWAT sections prepared from 
paraffin-embedded samples and stained with hematoxylin and eosin. Images 
were analyzed using a CCD camera (Nikon, Japan) at 20× magnification, and 
adipocyte area was measured using the Image J program. Values are the 
average of three sections per animal (7 animals per group).   
 
2.6. Immunofluorescence 
Paraffin sections of eWAT were dewaxed and then hydrated. After a 5 min 
wash with PBS, samples were incubated overnight with 50 mM ClNH4 under UV 
light. After 3 washes with PBS, samples were blocked with BSA in PBS 
(1mg/ml) for 2 h with gentle agitation at room temperature. Samples were 
washed and sections incubated with the primary antibody (dilution 1:50 in PBS) 
overnight at 4° C. Sections were subsequently washed and incubated with an  










2 h at room temperature. After washing and drying, sections were mounted with 
Fluoroshield (Sigma-Aldrich, USA). Images were obtained in a confocal 
microscope-Olympus-FV-1000 (Japan).  
 
2.7. Cell culture and incubations 
Mouse embryo 3T3-L1 pre-adipocyte cells line were cultured in complete 
medium (CM) consisting of Modified Medium from Dulbecco Eagle (DMEM) rich 
in glucose supplemented with 10% fetal bovine serum (FBS) (v/v), 1% 
penicillin/streptomycin and 2 mM glutamine in an atmosphere of 5% (v/v) CO2 
at 37° C. After 2 d of confluence (d 0), differentiation was started by incubating 
the cells with induction medium: CM supplemented with 1M 
isobutylmethylxanthine, 1μM dexamethasone and 1mM insulin for 48 h, 
followed by CM supplemented with insulin for additional 48 h. At (d 0), cells 
were treated without or with 20 ng/mL TNFα, as previously described by 
Hammarstedt et al. [19], and in the absence or the presence of 1 and 10 μM Q 
(Q1 and Q10) or of the Q metabolite quercetin 3-glucuronide (G1 and G10), and 
were replaced with the change of culture media. 
 
2.8. Statistical analysis 
Data are shown as mean ± S.E.M. Statistical significances were assessed by 
one-way ANOVA followed by Bonferroni’s Multiple Comparison Test. GraphPad 
Prism version 5.00 for Windows (Graph-Pad Software, San Diego, CA, USA) 













3.1. Effect of Q on metabolic parameters in rats fed a high-fat diet  
The effects of Q supplementation on metabolic parameters in rats fed for 6 w 
control, high-fat diet, or Q-supplemented high fat diets are shown in Table 1. 
Daily food intake was lower in the HFD and HFD+Q compared to the Ctrl group, 
although the average energy intake was similar for all groups. No statistically 
significant differences were observed in body weight, plasma glucose, TG, HDL, 
total cholesterol and FFA concentrations among groups. On the other hand, 
TNFα plasma concentration was increased in the HFD compared to the Ctrl 
group, while Q supplementation prevented high-fat diet-increased TNFα 
concentrations. 
Rats fed the high-fat diet had lower ability to metabolize circulating glucose 30 
min after performing the GTT when compared to the Ctrl group (Fig. 1A). The 
GTT area under the curve (AUC) was significantly higher in the HFD compared 
to Ctrl and HFD+Q groups (Fig. 1B). High-fat diet consumption caused high 
levels of plasma fasting insulin and HOMA: IR values after 6 w on the diet. Both 
changes were prevented by Q supplementation (Fig. 1C and D). Together, data 
indicate that Q supplementation attenuates high-fat diet-induced glucose 
intolerance, IR and inflammation. 
 
 
3.2. Q increased brown adipose weight and prevented high-fat diet-
induced adipocyte hypertrophy 
Consumption of a high-fat diet significantly increased eWAT weight and 
adipocyte size compared to the Ctrl group. The addition of Q to the high-fat diet 
did not modify eWAT weight, but significantly reduced adipocyte size (Table 1 










significant increase BAT weight compared to the HFD and Ctrl groups, 
respectively (Table 1).  When the eWAT/BAT ratio was calculated, we observed 
a significantly increased eWAT/BAT ratio in HFD rats, which was prevented 
upon Q supplementation (Table 1). Overall, these results indicate that Q 
supplementation increased BAT mass and prevented high-fat diet-induced 
adipocyte hypertrophy in rats fed a high fat diet. 
 
3.3. Effect of Q on HIF-1α, angiogenesis and adipogenesis in the eWAT 
from rats fed a high-fat diet 
In order to explore whether Q could reduce the size of adipocytes, proteins 
involved in angiogenesis and adipogenesis were measured in eWAT by 
Western blot (Fig. 3). Consumption of the high-fat diet increased HIF-1α protein 
levels and reduced those of VEGF-A and VEGF-R2. Q supplementation 
significantly reduced HIF-1α levels and increased both angiogenic factors, 
VEGF-A and VEGF-R2 (Fig. 3.A). 
In mammalian cells transcription factors PPARγ and C/EBPα, β and δ, are 
considered the main regulators of early adipogenesis, whereas adiponectin and 
fatty acid synthase (FAS) are responsible for mature adipocyte formation. 
Therefore, protein levels of PPARγ, C/EBPα, adiponectin and FAS were 
measured as parameters of adipogenesis in the eWAT (Fig. 3.B). Chronic 
consumption of the high-fat diet caused downregulation of PPARγ, C/EBPα, 
adiponectin and FAS. All this changes were prevented by Q supplementation. 
The above results indicate that Q can mitigate high-fat diet-induced adipose 











3.4. Supplementation with Q attenuated high-fat diet-induced adipose 
tissue inflammation 
Macrophages are crucial contributors to the inflammatory process at local 
(adipose tissue) and systemic levels. Together with ER stress, macrophages 
contribute to the development and perpetuation of adipose tissue inflammation 
induced by obesity (Fig. 4). 
Western blot analysis showed that a high-fat diet consumption increased 
adipose tissue macrophage infiltration and inflammation, as evidenced by 
higher eWAT levels of TLR-4, CD68, MCP-1, and phosphorylated 
(Thr183/Tyr185) JNK, and ER stress markers as ATF-6 and XBP-1. Q 
supplementation attenuated high-fat diet-induced TLR-4 increase and reduced 
CD68, MCP-1, p-JNK and ER stress protein expression (Fig. 4A and C). The 
activation of TLR-4 in the HFD was confirmed by immunofluorescence in 
histological sections of eWAT (Fig. 4B). These results confirm that consumption 
of a high-fat diet stimulates macrophage infiltration in the eWAT, as evidenced 
by a higher expression of the macrophage marker CD68, which was prevented 
by Q supplementation. 
3.5. Effects of Q and quercetin 3-glucuronide on proteins involved in 
adipogenesis in 3T3-L1 pre-adipocytes treated with TNFα 
In order to evaluate the effects of inflammation during early adipocyte 
differentiation, 3T3-L1 pre-adipocytes were induced to differentiate and 










absence or the presence of 1 and 10 μM Q (Q1 and Q10) or quercetin 3-
glucuronide (G) (G1 and G10).  
TNFα significantly reduced adipogenesis by approximately 50%, as evidenced 
by lower protein levels of PPARγ, C/EBPα, FAS and adiponectin compared to 
non-treated cells (Fig. 5). Incubation with Q 1-10 µM and G 10 µM significantly 
increased PPARγ levels compared to TNFα-treated cells (37, 39 and 38%, 
respectively). Q (10 µM) and G (1-10 µM) significantly increased C/EBPα, while 
both concentrations of Q and G increased FAS protein levels, to values of 
control non-treated cells. In addition, Q (1-10 µM) and G at 1 µM significantly 
increased adiponectin levels compared to TNFα treated cells (Fig. 5). Overall, 
Q and G attenuated TNFα-impaired adipogenesis in pre-adipocyte 3T3-L1 cells. 
4. Discussion 
Chronic consumption of a high-fat diet increased adiposity, adipose 
hypertrophy, and inflammation in rats, leading to the development of IR. 
Simultaneous consumption of Q significantly reduced the adipocyte size, 
attenuated adipose inflammation, and prevented systemic IR. These effects can 
be attributed, in part, to the capacity of Q to stimulate a healthy adipose tissue 
expansion promoting adipose angiogenesis and adipogenesis. 
As a consequence of a continuous excess of energy availability, adipose tissue 
vascularization may be insufficient to maintain tissue normoxia. Under hypoxic 
conditions, adipose tissue increases the synthesis of inflammatory cytokines, in 
part due to HIF-1 activation, contributing to increased macrophage infiltration 
and inflammation [20]. In addition, the type of dietary fats (saturated fats) as 
well as an increase in circulating free fatty acids stimulates the activation of 










the transcription of several genes involved in the inflammatory response, such 
as pro-inflammatory cytokines, and the recruitment of pro-inflammatory 
macrophages, contributing to low-grade chronic inflammation and IR [5]. 
Accordingly, we currently observed that the presence of hypertrophic and 
hypoxic adipocytes in the eWAT of the HFD group were accompanied with an 
increased expression of TLR-4, CD68 (parameter of macrophage infiltration), 
the chemokine MCP-1 and the pro-inflammatory kinase JNK. Activation of this 
pathways leads to the transcription of pro-inflammatory cytokines that contribute 
to a cycle of chronic inflammation. In agreement, the HFD group was 
accompanied with increased TNFα plasma concentration.  
Given the secretory capacity of adipose tissue, the metabolic stress induced by 
excess nutrients and hypertrophy can lead to oxidative stress and accumulation 
of missfolded proteins in the lumen of the ER causing dysfunction of organelles, 
in particular of mitochondria and the ER. ER stress regulates adipocytes 
inflammation in obese rats through TLR-4 signaling [4]. In this sense, the 
reduction of adipose tissue and the metabolic improvement in obese patients 
undergoing bariatric surgery is associated with a downregulation of ER stress 
evidenced by a decrease in JNK and XBP-1 activation [21]. We observed that Q 
mitigated TLR-4 activation and the expression of CD68, MCP-1 and ER stress 
associated with fat consumption, together with a reduction of TNFα plasma 
concentration, while increased the anti-inflammatory and insulin sensitive 
cytokine (adiponectin). These data suggest that Q could counteract high fat 
diet-induced macrophage infiltration and inflammation in the adipose tissue. In 










macrophages 264.7 through the positive regulation of Tollip expression (a 
negative regulator of TLR signaling) [22].  
It is known that adipose hypertrophy promotes tissue inflammation and 
dysfunction, while a reduction of adipocyte diameter, even in the absence of 
adipose tissue mass decrease, may prevent these alterations [3]. Accordingly, 
chronic consumption of a high-fat diet increased eWAT weight and caused 
adipocyte hypertrophy while supplementation with Q reduced adipose 
hypertrophy, without modifying the eWAT weight. These can be in part 
attributed to the capacity of Q to prevent high-fat diet-mediated increase in 
adipose protein levels of HIF-1α and proteins that participate in angiogenesis 
and adipogenesis [23, 24].  These findings also suggest that Q promotes 
hyperplasia instead of hypertrophy. However, considering the increased BAT 
weight and the decreased eWAT/BAT ratio observed in the HFD+Q we could 
also assume an increase in energy expenditure. Consistently, we previously 
showed that Q up-regulates proteins involved in mitochondrial biogenesis in 
3T3-L1 adipocytes treated with palmitate [15]. In addition, Q promotes WAT 
brown-like adipocyte appearance in mice and in 3T3-L1 cells [25, 26]. 
Therefore, we cannot discard a possible increase of BAT thermogenesis and/or 
browning effect on WAT. 
There are controversial and contradictory results in the literature based on the 
inhibitory effects of polyphenols, including Q, on adipogenesis and 
angiogenesis. Q suppressed adipogenesis by reducing the expression of 
C/EBPα, PPARγ and inflammatory cytokines in 3T3-L1 cells and in a mouse 
model of obesity [27].  Q also suppressed lipogenesis by reducing the rate of 










expression of FAS and acetyl CoA-carboxylase [28]. Q also inhibits PPARγ and 
C/EBPα expression in 3T3-L1 pre-adipocytes at very high concentrations (50-
100 μM), while at lower concentrations (10 μM) the opposite effect was 
observed [28]. In addition, Q (10 μM) promoted adipogenesis in human 
mesenchymal stem cells [24]. Many authors suggest that adipose tissue 
angiogenesis and/or adipogenesis inhibition could be a strategy to prevent 
adipose tissue growth and obesity. However, an impairment of adipogenesis 
may lead to hypertrophic adipocytes, increased ectopic fat deposition, and IR 
[29]. In line with this, obese mice that overexpress adiponectin showed higher 
expression of PPARγ in the adipose tissue, increased in adipocyte cell number 
and adipose tissue mass, had lower macrophage infiltration, and reduced 
systemic inflammation with normalized metabolic parameters [30]. We have 
previously shown that Q attenuates/prevents high fructose or TNFα-induced 
expression of pro-inflammatory adipocytokines (visfatin, resistin and MCP-1) 
and increases the expression of adiponectin in the visceral adipose tissue and 
in 3T3-L1 adipocytes, respectively [12]. In addition, incubation with TNFα (50 
ng/mL) for 24 h decrease the transcription of the PPARγ gene and the 
expression of C/EBPδ and its binding to DNA in 3T3-L1 pre-adipocytes during 
early adipocytes differentiation [7], which suggest that inflammation could be a 
key factor of early interruption of adipogenesis associated with increased IR 
[31]. Accordingly, in this study we observed that Q and quercetin 3-glucuronide 
attenuated TNFα-induced  alterations in proteins involved in early adipocyte 
differentiation in 3T3-L1 pre-adipocytes (PPARγ and C/EBPα, and key proteins 










In summary, the capacity of Q to modulate: i) adipose tissue hypertrophy 
(decreased adipose diameter), ii) the consequent activation of the redox 
sensitive pathways JNK and TLR-4, and iii) ER stress; would converge in the 
mitigation of the inflammation-induced IR associated to consumption of a high- 
fat diet in rats. These findings support the potential relevance of consuming Q-
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Table 1. Q supplementation effects on metabolic parameters in rats with a 
high-fat diet. 
 
Parameter          Ctrl            HFD     HFD+Q 
Food intake (g) 28.5 ± 1.4a 18.7 ± 0.9b 19.3 ± 1.2b 
Energy intake (Kcal/d) 89.7 ± 6.0 88.1 ± 7.4 91.0 ± 7.9 
Body weight (BW) (g) 450.0 ± 12.9 478.6 ± 10.3 459.0 ± 22.6 
Fasted glucose (mg/dl) 100.0 ± 1.9 109.0 ± 2.3 103.0 ± 3.3 
eWAT (mg)/BW  805.0 ± 33.9a 1628.0 ± 117.0b 1311.0 ± 122.0b 
BAT (mg)/BW  98.4 ± 5.5a 121.0 ± 13.6a,b 150.0 ± 11.1b 
eWAT/BAT 9.0 ± 1.0a 13.6 ± 1.1b 7.2 ± 1.0a 
TG (mg/dl) 55.8 ± 8.4 64.0 ± 4.7 73.4 ± 0.8 
Total cholesterol 
(mg/dl) 
70.3 ± 4.9 63.8 ± 3.3 64.8 ± 7.7 
HDL cholesterol (mg/dl) 33.6 ± 0.8 30.2 ± 1.3 31.30 ± 2.3 
FFA (mEq/L) 1.5 ± 0.1 1.6 ± 0.1 1.5 ± 0.1 
TNFα (pg/ml) 5.4 ± 0.3a 6.9 ± 0.4b 5.8 ± 0.2 a 
Food intake and metabolic parameters of rats fed a control (Ctrl) or a high-fat 










(HFD+Q). Results are shown as the mean ± SEM of seven animals/treatment. 
Values having different superscripts are significantly different (p < 0.05, one-
way ANOVA). 
 
Legend to Figures:  
Figure 1. Effects of Q supplementation on metabolic parameters in rats 
fed a high-fat diet. (A-D) Rats were fed a control (Ctrl) (white bars) or a high-
fat diet without (HFD) (black bars) or with supplementation with Q (20 mg/kg 
body weight/d) (HFD+Q) (grey bars) for 6 weeks. (A) Glucose tolerance test 
(GTT) was done after 4 weeks on the respective diets, (B) area under the curve 
for the GTT, (C) plasma insulin concentration and (D) HOMA:IR. Results are 
shown as mean ± SEM of seven animals/group. Values having different 
superscripts are significantly different (p < 0.05, one-way ANOVA). 
 
Figure 2. Effect of dietary Q supplementation on adipocyte area in eWAT 
from rats fed a high-fat diet. Rats were fed a control (Ctrl) (white bars) or a 
high-fat diet without (HFD) (black bars) or with supplementation with Q (20 
mg/kg body weight/d) (HFD+Q) (grey bars) for 6 weeks. (A) Representative 
histological images of eWAT stained with hematoxylin and eosin (scale 50 µm), 
and (B) mean adipocyte diameter in eWAT. Results are shown as mean ± 
S.E.M. of seven animals/group. Values having different superscripts are 











Figure 3. Effect of dietary Q supplementation on proteins involved in 
hypoxia, angiogenesis and adipogenesis in the eWAT of rats fed a high-fat 
diet. Rats were fed a control (Ctrl) or a high-fat diet without (HFD) or with 
supplementation with Q (20 mg/kg body weight/d) (HFD+Q) for 6 weeks. (A) 
HIF-1α, VEGF-A and VEGF-R2, and (B) PPARγ, C/EBPα, adiponectin and FAS 
protein levels in the eWAT were measured by Western blot. Bands were 
quantified and values normalized to β-actin levels (loading control). Results 
were referred to control group values (Ctrl). Results are shown as the mean ± 
SEM of seven animals/group. Values having different superscripts are 
significantly different (p < 0.05, one-way ANOVA).  
 
Figure 4. Q attenuated adipose tissue inflammation in rats fed a high-fat 
diet.  Rats were fed a control (Ctrl) or a high-fat diet without (HFD) or with 
supplementation with Q (20 mg/kg body weight/d) (HFD+Q) for 6 weeks. (A) 
Protein levels of the inflammatory parameters TLR-4, CD68 and MCP-1 were 
measured by Western blot, (B) representative images of TLR-4 determined by 
immunofluorescence in sections of eWAT. From top to bottom: Ctrl, HFD and 
HFD+Q. Histological sections were examined by light field microscopy (right) 
and fluorescence (left) (scale 5 µm). Color bars indicate greater intensity at a 
greater number. Magnified areas are indicated with a box, (C) p-JNK, JNK, 
ATF-6 and XBP-1 protein levels in the eWAT were measured by Western blot.  
(A, C) Bands were quantified and values referred to β-actin levels (loading 
control), except for p-JNK that was normalized to total JNK levels. Results were 










five animals/group. Values having different superscripts are significantly 
different (p < 0.05, one-way ANOVA).  
 
Figure 5. Effect of Q and quercetin 3-glucuronide on adipogenic factors in 
3T3-L1 pre-adipocytes. 3T3-L1 pre-adipocytes were incubated with or without 
Q and G (1-10 μM) for 4 d, and in the absence or the presence of TNFα (20 
ng/mL). Protein levels of PPARγ, C/EBPα, FAS and adiponectin were 
determined by Western blot. Western blot bands were quantified and values 
normalized to β-actin levels (loading control). Results were referred to control 
group values (Ctrl). Results are shown as mean ± SEM of 3 independent 
experiments. Values having different superscripts are significantly different 
(p<0.05, one way ANOVA test).  
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